Evoke is a hands-free device designed for the face and subdermal area. The radio frequency-based platform addresses patient aesthetic concerns using controlled heating of the skin and subnormal tissue.
“The idea of a facial hands-free treatment has been circulating in the market for about eight years,” chief technology officer Michael Kreindel said in a news release. “I’m proud that InMode, after years fo research and development, is the first company to bring this solution to patients worldwide.”
InMode in August las year closed its initial public offering, grossing $70 million for its radio frequency devices for aesthetic medical procedures.
“Evoke delivers the ultimate solution in thermal facial procedures. Patients can not only turn back the hands of time but are now also able to achieve long-lasting structural enhancements to their face without excisions surgery. InMode once again has brought to market another aesthetics industry game-changer,” chief medical officer Spero Theodorou said.